Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Perspectives on diabetic retinopathy.

Lloyd M Aiello1

  • 1Department of Opthalmolofy, Harvard Medical School, Boston, Massachusetts, USA. Lloyd.M.Aiello@joslin.harvard.edu

American Journal of Ophthalmology
|July 2, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disparities Between Teleretinal Imaging Findings and Patient-Reported Diabetic Retinopathy Status and Follow-up Eye Care Interval: A 10-Year Prospective Study.

Diabetes care·2024
Same author

Diabetic Retinopathy Severity and Peripheral Lesions Are Associated with Nonperfusion on Ultrawide Field Angiography.

Ophthalmology·2015
Same author

Peripheral Lesions Identified on Ultrawide Field Imaging Predict Increased Risk of Diabetic Retinopathy Progression over 4 Years.

Ophthalmology·2015
Same author

Potential efficiency benefits of nonmydriatic ultrawide field retinal imaging in an ocular telehealth diabetic retinopathy program.

Diabetes care·2013
Same author

Peripheral lesions identified by mydriatic ultrawide field imaging: distribution and potential impact on diabetic retinopathy severity.

Ophthalmology·2013
Same author

Comparison of low-light nonmydriatic digital imaging with 35-mm ETDRS seven-standard field stereo color fundus photographs and clinical examination.

Telemedicine journal and e-health : the official journal of the American Telemedicine Association·2012
Same journal

Performance of the ISOLD Score (Interleukin Score for IntraOcular Lymphoma Diagnosis) in the Diagnosis of Vitreoretinal Lymphoma in Clinical Practice.

American journal of ophthalmology·2026
Same journal

Reply to Comment on Visual Field Progression in Glaucoma Patients with Delayed Follow-Up.

American journal of ophthalmology·2026
Same journal

Comment on: "Safety and efficiency reducing retinopathy of prematurity guideline sensitivity: an external validation using a large US-based dataset".

American journal of ophthalmology·2026
Same journal

Reply to Comment on "Clinicopathological and Imaging Distinction Between Ocular Adnexal MALT Lymphoma and IgG4-Related Ophthalmic Disease".

American journal of ophthalmology·2026
Same journal

Comment on: Visual Field Progression in Glaucoma Patients With Delayed Follow-Up.

American journal of ophthalmology·2026
Same journal

Corneal sensitivity changes and nerve plexus abnormalities in noninfectious anterior uveitis.

American journal of ophthalmology·2026
See all related articles

Diabetic retinopathy (DR) is a leading cause of blindness, but timely detection and evidence-based treatments, including laser photocoagulation and glycemic control, can prevent vision loss. Future therapies aim to cure retinal complications.

Area of Science:

  • Ophthalmology
  • Endocrinology
  • Diabetology

Background:

  • Diabetic retinopathy (DR) is a microvascular complication of diabetes mellitus, a significant cause of new-onset blindness.
  • The Diabetic Retinopathy Study pioneered multicentered trials, establishing scatter photocoagulation for DR treatment.
  • Subsequent trials like the Early Treatment Diabetic Retinopathy Study elucidated DR's natural history and confirmed laser photocoagulation for proliferative DR and macular edema.

Discussion:

  • The Diabetes Control and Complications Trial and United Kingdom Prospective Diabetes Study demonstrated intensive glycemic control's efficacy in reducing DR onset and progression.
  • Current clinical practice emphasizes timely detection, evidence-based treatments, and comprehensive diabetes care for preventing vision loss.
  • Long-term follow-up is crucial for managing diabetic eye disease.

Related Experiment Videos

Key Insights:

  • Severe vision loss from diabetes is preventable with early detection and appropriate interventions.
  • Laser photocoagulation is a proven treatment for proliferative diabetic retinopathy and diabetic macular edema.
  • Intensive glycemic control is fundamental in managing diabetic retinopathy and other microvascular complications.

Outlook:

  • Future treatments will focus on the biochemical basis of DR to cure or prevent retinal complications.
  • Advancements in understanding DR's pathogenesis may lead to novel therapeutic strategies.
  • Continued research into diabetes management and its ocular manifestations is essential.